RitaAssiMD

Hematologic Oncology

Assistant Professor of Medicine

Dr. Assi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

65 citations
Appendiceal Mucinous Neoplasms: Diagnosis and Management.
Walid L Shaib, Rita Assi, Ali Shamseddine, Olatunji B Alese, Charles Staley 3rd
The Oncologist. 2017-09-01
49 citations
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms
Rita Assi, Hagop M. Kantarjian, Guillermo Garcia-Manero, Jorge E. Cortes, Naveen Pemmaraju
American Journal of Hematology. 2018-02-01
41 citations
The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia.
Mansour Alfayez, Ghayas C. Issa, Keyur P. Patel, Feng Wang, Xuemei Wang
Leukemia. 2021-03-01

Abstracts/Posters

Sequencing of Circulating Cell-Free DNA in Patients with AML Detects Clinically Significant Mutations Not Detected in Bone Marrow: The Role for Complementary Periphera...
Rita Assi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Final Results of Phase I/II Study of Selinexor (SEL) with Sorafenib in Patients (pts) with Relapsed and/or Refractory (R/R) FLT3 Mutated Acute Myeloid Leukemia (AML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) Associated Mutations and Risk of Comorbidities in Patients with Myelodysplastic Syndrome
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Diverse Landscape of TET2 Variants in MDS and AML
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018